Carey Gillam's profile photo

Carey Gillam

Kansas City

Columnist and Contributor at The Guardian

Managing Editor at The New Lede

Journalist -Managing Editor of @TheNewLedeNews; 17 years @Reuters; Author of Whitewash & The Monsanto Papers; @Guardian contributor, @nytimes freelancer

Articles

  • 1 week ago | thenewlede.org | Carey Gillam

    Bayer this week put a halt to its latest courtroom battle over allegations that its weed killing products cause cancer, settling a Missouri case after four weeks of testimony and just as the trial was coming to a close and just ahead of important US Supreme Court consideration.

  • 1 week ago | thenewlede.org | Carey Gillam

    (This column first appeared in the Ecdysis Foundation newsletter.)By Dr. Ryan Schmid In our race to “feed the world”, farmers and ranchers have been pressed into a system that manufactures food for a growing global population. Farmers have met these challenges head-on, producing an abundance of crops and meat; however, our production of abundance has not come without costs.

  • 1 week ago | theguardian.com | Carey Gillam

    Six months ago, Alex Hammer was diagnosed with colon cancer at the age of 37. Dianne Chambers endured surgery, chemotherapy and dozens of rounds of radiation to fight aggressive breast cancer, and Janan Haugen spends most days helping care for her 16-year-old grandson, who is still being treated for brain cancer he developed at the age of 7. The three were among a group of about two dozen people who came together last week in a small town in central Iowa to share their experiences of cancer.

  • 1 week ago | thenewlede.org | Carey Gillam

    INDIANOLA, Iowa – Six months ago, Alex Hammer was diagnosed with colon cancer at the age of 37. Dianne Chambers endured surgery, chemotherapy and dozens of rounds of radiation to fight aggressive breast cancer, and Janan Haugen spends most days helping care for her 17-year-old grandson, who is still being treated for brain cancer he developed at the age of 7.

  • 2 weeks ago | thenewlede.org | Carey Gillam

    A new long-term animal study of the widely used weed killer glyphosate find fresh evidence that the herbicide, introduced by Monsanto in the 1970s, causes multiple types of cancer, and may do so at doses considered safe by regulators. The results of the two-year study, which were published June 10 in the journal Environmental Health, add to an ongoing global debate over the safety of the pesticide, which is commonly used by farmers to kill weeds in fields and pastures.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

Coverage map

X (formerly Twitter)

Followers
16K
Tweets
8K
DMs Open
Yes
carey gillam ✍️ 📓
carey gillam ✍️ 📓 @careygillam
4 Jun 25

Several trials have been set to start in the last two years, but in each case, @Syngenta has successfully obtained delays. https://t.co/6ORREFtyLY @Bayer @thenewledenews

carey gillam ✍️ 📓
carey gillam ✍️ 📓 @careygillam
4 Jun 25

The latest in Trump's race to extinction... "Since 1998, the Chemical Safety Board has played a key role in probing the causes of major chemical accidents." https://t.co/2l7BUow1nM

carey gillam ✍️ 📓
carey gillam ✍️ 📓 @careygillam
2 Jun 25

So interesting watching yet another Roundup trial unfold, and Monsanto toxicologist Donna Farmer testifying today how ghostwriting doesn't really mean ghostwriting... Thanks @CourtroomView for webcasting the live action. https://t.co/uQXJ9j91la